Latest / Ageless and Timeless Podcast® / James White, CEO and Owner KBMO Diagnostics
Transcript
- 0:08Speaker 1: Hey, everybody, this is Michelle Hughes from Ageless and Timeless.
- 0:12Speaker 1: Today I have a guest that has been a previous
- 0:15Speaker 1: guest on our podcast. We often do this after a
- 0:18Speaker 1: couple of years because there's so much that happens with
- 0:21Speaker 1: these technologically based companies, and we also want be sure
- 0:27Speaker 1: that our newer viewers get to experience the amazing guests
- 0:33Speaker 1: that we have who want to share so much information
- 0:37Speaker 1: for us. So today our guest is James White, and
- 0:40Speaker 1: he is the founder and CEO of KBM Diagnostics, which
- 0:46Speaker 1: stands well, actually, he'll tell us, but it's kind of
- 0:50Speaker 1: fun because it's a family feeling business even though it's
- 0:55Speaker 1: a major business in the industry of tests for the microbion,
- 1:01Speaker 1: the health of the microbion. But his company name came
- 1:07Speaker 1: from the names of his wife Catherine, his son Ben,
- 1:12Speaker 1: his other son Max, and his daughter Olivier. Olivier I
- 1:17Speaker 1: guess it is, and is that correct. James have a
- 1:22Speaker 1: good memory from that, so it is. It's kind of
- 1:27Speaker 1: cute because it shows who his real bosses are, not
- 1:33Speaker 1: just the consumers, but the bosses at home. So James, welcome,
- 1:38Speaker 1: and I'm so happy you could come back and we're
- 1:43Speaker 1: happy this time that we can do it in video.
- 1:45Speaker 1: So last time we had a technical difficulty, so we
- 1:49Speaker 1: had audio only.
- 1:51Speaker 2: Why didn't you tell us start off?
- 1:53Speaker 1: Just because the people who haven't heard you before, tell
- 1:57Speaker 1: us what KBMO does and why your unique and how
- 2:02Speaker 1: you differentiate yourself from your competition.
- 2:07Speaker 3: Sure that I'll keep it going for a little while,
- 2:10Speaker 3: but I'll start trying to kind of keep it keep
- 2:13Speaker 3: it simple for everyone.
- 2:15Speaker 4: Yeah, So the idea about KBMO we were set up.
- 2:19Speaker 3: Just over fourteen years ago now, and the idea was
- 2:21Speaker 3: to look at how we can look at food sensitivities
- 2:25Speaker 3: and work out on an individualized basis, how can we
- 2:29Speaker 3: improve patient care. So there's a lot of one size
- 2:33Speaker 3: fits all, and we all know that that's pretty poor,
- 2:36Speaker 3: a poor model. So what I wanted to do was
- 2:38Speaker 3: come up with a way of identifying which foods cause
- 2:42Speaker 3: patients an inflammatory response on an individualized basis. And so
- 2:47Speaker 3: the reason we wanted to do that is, and I'm
- 2:49Speaker 3: sure Michelle's had lots of guests on before talking about
- 2:54Speaker 3: root cause analysis. So what we're trying to do is
- 2:57Speaker 3: get to the root cause. I ua your diet, which
- 3:01Speaker 3: foods lead to an inflammatory response, And so that's what
- 3:06Speaker 3: we're about, is to try to work out how we
- 3:09Speaker 3: can give the patient and provider a way of identifying
- 3:12Speaker 3: which food the patient's consuming are leading to an inflammatory
- 3:17Speaker 3: response unbeknownst to that patient. So again, there's nothing that
- 3:21Speaker 3: the patient's doing wrong, but what we want to do
- 3:23Speaker 3: is give them the knowledge and the power to say, Okay,
- 3:26Speaker 3: if I can continue to consume this food, it's going
- 3:29Speaker 3: to lead to an inflammatory response. And basically inflammation is
- 3:34Speaker 3: the root cause of pretty much every disease state. So
- 3:36Speaker 3: what we want to try and work out is based
- 3:39Speaker 3: on something that we all do at least three times
- 3:41Speaker 3: a day is work out what are we consuming to
- 3:44Speaker 3: make sure that it's not leading to an inflammatory response
- 3:49Speaker 3: by doing this great test which identifies on an individualized
- 3:52Speaker 3: basis which food cause you the patient an inflammatory response,
- 3:57Speaker 3: and so that inflammation is shown, as.
- 4:00Speaker 4: I mentioned, in a myriad of symptoms.
- 4:02Speaker 3: So the classical thing with food has always been gut related,
- 4:05Speaker 3: but now we're seeing, as we kind of work all
- 4:08Speaker 3: these things out, the links between leaky gut and leaky brain,
- 4:12Speaker 3: or as a number of our colleagues who are neurologists
- 4:15Speaker 3: now tell us, it's leaky brain leading to leaky gut.
- 4:18Speaker 3: So what we're trying to work out for you is
- 4:21Speaker 3: which foods that we're all consuming are causing that inflammatory response.
- 4:25Speaker 3: And so that really what we are about and how
- 4:29Speaker 3: we differentiate ourselves is we look at this by multiple pathways.
- 4:34Speaker 3: So rather than just assuming what we're exposed to is
- 4:38Speaker 3: causing the foods is causing the inflammation, we're looking at
- 4:43Speaker 3: best described by one of our practitioners in Ohio who said, look, James,
- 4:48Speaker 3: this test is different. It's patented, which is great, and
- 4:51Speaker 3: you're the only food sensitively tests on the market which
- 4:53Speaker 3: is patented, but also you look at a whole immune system,
- 4:57Speaker 3: and without getting too scientific on that, what it means
- 5:00Speaker 3: is rather than just looking at what you're exposed to,
- 5:04Speaker 3: which is half of your immune system measures your exposure,
- 5:08Speaker 3: where we really differentiate ourselves is we also look at
- 5:11Speaker 3: what it's called the innate immune system eye which of
- 5:14Speaker 3: those foods that you're exposed to also goes on to
- 5:17Speaker 3: then lead to an inflammatory response. And that's the big
- 5:21Speaker 3: difference between KBMO and all the other myriad companies out
- 5:24Speaker 3: in the market is they're telling you what you're exposed to,
- 5:28Speaker 3: which i'd argue is a bit of a so what,
- 5:29Speaker 3: Because we all know what we're eating. What we want
- 5:32Speaker 3: to tell you is more importantly of what you're eating
- 5:35Speaker 3: which ones are actually causing inflammation. And the great thing
- 5:38Speaker 3: about that secondary screen it helps, in technical jargon eliminate
- 5:42Speaker 3: bols positives, But to you and I, what it really
- 5:45Speaker 3: means is we zero in on say five to ten
- 5:48Speaker 3: foods which we're asking patients to eliminate from their diet.
- 5:52Speaker 3: And the great thing about that elimination is generally it's
- 5:55Speaker 3: only three to six months, so it's not it's not forever.
- 5:58Speaker 3: But the idea is, let's identify a handful of foods which,
- 6:03Speaker 3: by looking at this patterned process, really zeros in on
- 6:07Speaker 3: the foods which cause you inflammation, which then correlate really
- 6:11Speaker 3: strongly with whatever those symptoms are that you present with
- 6:14Speaker 3: when you go in to see your provider. And we're
- 6:17Speaker 3: fortunate we have just over ten thousand providers running the
- 6:19Speaker 3: test now and so again we're widely available all around
- 6:22Speaker 3: the US and globally to kind of now access the test,
- 6:26Speaker 3: so we can kind of get patients to do it.
- 6:28Speaker 3: The other cool thing about what we do, it's a
- 6:30Speaker 3: finer stick, so you can do it in the comfort
- 6:32Speaker 3: of your own home. And so again you can get
- 6:35Speaker 3: it through providers and they'll enable you either to do
- 6:38Speaker 3: it in their offices or more importantly, you can do
- 6:40Speaker 3: it at home as well. So again we've tried to
- 6:42Speaker 3: make it a widely accessible but again we value the
- 6:48Speaker 3: review that you can then have with your provider to
- 6:51Speaker 3: make sure we understand what's going on from a dietary
- 6:54Speaker 3: standpoint along with what else is you're going. So we
- 6:58Speaker 3: would describe our provider's being one percent of providers who
- 7:02Speaker 3: really care about what you're consuming to make sure they
- 7:05Speaker 3: bear that in mind on an individualized basis when they
- 7:08Speaker 3: treat you the patient.
- 7:10Speaker 1: And so how do you differentiate yourself And let's say
- 7:13Speaker 1: some of the other tests like the spectra cell or
- 7:16Speaker 1: the doctor's data or.
- 7:17Speaker 3: You know the like I say, all those guys great companies,
- 7:21Speaker 3: they're generally measuring a pathway which is called IgG. And
- 7:25Speaker 3: that is that half of your immune system that we
- 7:28Speaker 3: talked about. So we don't stop at that point because
- 7:31Speaker 3: that is broadly Again, if you talked to any aalogists
- 7:34Speaker 3: or so like, we don't believe in IgG testing. And
- 7:37Speaker 3: the reason they don't believe in it is because again
- 7:40Speaker 3: those you've just mentioned some fantastic companies, you know, best
- 7:43Speaker 3: in class. I would argue all the way through there,
- 7:46Speaker 3: but the limitation isn't those companies, it's that pathway, because
- 7:49Speaker 3: that pathway is only telling you what you're exposed to.
- 7:53Speaker 4: What we believe is way more important is rather than
- 7:55Speaker 4: stopping at that point.
- 7:56Speaker 3: We believe that's where the magic happens with KBMO is
- 7:59Speaker 3: because you're now going on to look at of that
- 8:01Speaker 3: long list of foods you're exposed to, which ones are
- 8:04Speaker 3: truly causing an inflammatory response. Back to what we call
- 8:09Speaker 3: what we spoke about earlier, I the root cause of
- 8:12Speaker 3: what symptoms you're presenting with.
- 8:14Speaker 4: And so obviously there's other things.
- 8:16Speaker 3: That will impact why you're sick, but clearly your diet
- 8:21Speaker 3: is an important element to that. And what we always
- 8:24Speaker 3: hear from the best providers that we work with, and
- 8:26Speaker 3: we're fortunately we work with many of them, is that
- 8:29Speaker 3: view your body as an engine. When you buy a
- 8:32Speaker 3: new car, they'll tell you which gas to put in it,
- 8:35Speaker 3: or now I guess which electricity to put in it.
- 8:38Speaker 3: But the idea is what they're trying to work out
- 8:41Speaker 3: is for a car, the specific oils and things that
- 8:44Speaker 3: you should use that optimize that engine's performance. Your body
- 8:48Speaker 3: is no different. What we're trying to help you with
- 8:51Speaker 3: via the help of some of these great providers is
- 8:53Speaker 3: which are the foods which you need to eliminate to
- 8:56Speaker 3: make sure that your body can be in an optimum
- 8:59Speaker 3: state so that again you can fully function, you know,
- 9:02Speaker 3: as your program suggests, have significant longevity. And the great
- 9:08Speaker 3: thing about your diet it's something we can all impact.
- 9:10Speaker 3: It's not based on you know, on the pharmaceuticals or
- 9:14Speaker 3: drugs or anything like that. It's all based on what
- 9:17Speaker 3: you're actually putting into that engine or your body, and
- 9:20Speaker 3: so you have one hundred percent control of that.
- 9:23Speaker 1: So you are laser focused on food, which we all
- 9:27Speaker 1: know food is our medicine.
- 9:29Speaker 2: However, there are other environmental.
- 9:32Speaker 1: And and well, I guess environmental would be the easiest
- 9:37Speaker 1: one of the EMFs and the toxins and the pesticides
- 9:41Speaker 1: and all the other How do you collect, you know,
- 9:44Speaker 1: how do you put it all together in a in
- 9:48Speaker 1: a formula that obviously affects inflammation and affects illness. But
- 9:54Speaker 1: with food being your baseline and KBMO being the source
- 9:59Speaker 1: to determin many what those foods are, but how do
- 10:02Speaker 1: you factor in these other influencers on our total wellness.
- 10:09Speaker 5: Today's podcast is brought to you by Water and Wellness.
- 10:12Speaker 5: Water and Wellness is one of the best companies to
- 10:16Speaker 5: find purified water. They have a countertop system that I
- 10:21Speaker 5: use and I travel with it all the time. So
- 10:23Speaker 5: I would highly recommend you look at that. If you
- 10:26Speaker 5: use the ageless code, you'll get a ten percent discount.
- 10:30Speaker 5: Waterinwellness dot com Forward slash pages, forward slash, ageless and timeless.
- 10:37Speaker 5: That's how you can order to get the discount. So
- 10:40Speaker 5: visit Waterindwellness dot com or call eight seven seven two
- 10:44Speaker 5: nine six six eight eight zero to learn how to
- 10:47Speaker 5: take control of your drinking water and learn about all
- 10:50Speaker 5: those natural additives to optimize your health and longevity.
- 10:54Speaker 3: So we also look at equally important as your foods
- 10:57Speaker 3: are colorings and additives, because then to your point, you
- 11:01Speaker 3: mentioned some of those things or any Michelle, but the
- 11:03Speaker 3: key with all those colorings and additives, I argue we
- 11:06Speaker 3: live in a kind of three D world. You're seeing
- 11:08Speaker 3: them in three main areas. You're seeing them in processed foods,
- 11:12Speaker 3: You're increasingly seeing them in supplementation and Thirdly, you're seeing
- 11:16Speaker 3: them in personal hygiene products. So we're looking at those
- 11:19Speaker 3: colorings and additives to make sure that patients are aware
- 11:22Speaker 3: of what might be going on from a coloring additives perspective,
- 11:25Speaker 3: and so we measure those on the test as well.
- 11:27Speaker 3: And so what I found really interesting is that you
- 11:30Speaker 3: see those appear. And so again those three areas are
- 11:34Speaker 3: things that we can't really ignore in our lives. We're
- 11:36Speaker 3: all eating processed foods, unfortunately, given you what goes into
- 11:41Speaker 3: them now, and you know, there's all sorts of things
- 11:43Speaker 3: like these colorings. A classic example of that is the
- 11:46Speaker 3: red dye and I'm sure most people's favorite red velvet
- 11:49Speaker 3: cake was invented by bio pharmaceuticals after World War two
- 11:54Speaker 3: to color plastics.
- 11:56Speaker 4: So again, here we are sixty years on.
- 11:58Speaker 3: I'm not sure we've made much pro yes from the
- 12:00Speaker 3: fact that what we're looking at now is those coloring,
- 12:04Speaker 3: those colorings which instead of being I'm sure they are
- 12:07Speaker 3: being applied to plastics, but they're also in the food chain.
- 12:10Speaker 3: And so there's all these colorings and additives that have
- 12:12Speaker 3: appeared in the food chain that we're trying to eliminate
- 12:15Speaker 3: or should be eliminating given the toxicity that they're creating,
- 12:19Speaker 3: and as you quite rightly mentioned, there's other environmental issues
- 12:22Speaker 3: as well. But our view is by covering the key
- 12:25Speaker 3: foods that people are consuming and look at those colorings
- 12:28Speaker 3: and additives, you look at some of the key barriers
- 12:30Speaker 3: for patients in terms of the skin, the gut, and
- 12:34Speaker 3: you know what they're consuming. And so that's really important
- 12:36Speaker 3: in terms of what we're doing as an organization is
- 12:39Speaker 3: to try and cover off as many elements with a
- 12:42Speaker 3: single test, and so in a way that leads us
- 12:45Speaker 3: neatly into the kind of third element that we look
- 12:47Speaker 3: at is kind of gut health as well, because when
- 12:50Speaker 3: you look at what people are causing their inflammatory responses,
- 12:55Speaker 3: there's always been a kind of classical question. It's a
- 12:57Speaker 3: kind of chicken and egg which came birth with at
- 12:59Speaker 3: least key gut or food sensitivities. And again I would
- 13:03Speaker 3: argue the differentiator between our positions and some of the
- 13:06Speaker 3: others out there as they believe in both of those terms,
- 13:08Speaker 3: and so they understand that, you know, you need it's
- 13:12Speaker 3: tough to look at one without the other. And so
- 13:14Speaker 3: what we've done is rather than I guess being closed
- 13:17Speaker 3: to that is, we've now developed a panel that sits
- 13:21Speaker 3: alongside the food sensitivity test to look at your immune
- 13:25Speaker 3: health via your gut health. And again you've talked about
- 13:29Speaker 3: food being our medicine, and again that Hippocrates talked about,
- 13:32Speaker 3: you know, all disease begins in the gut. So again,
- 13:35Speaker 3: what we wanted to do was align those two elements
- 13:39Speaker 3: together to make sure that that's how to say differentiate
- 13:44Speaker 3: would be would be unfair. Completely puts US in a
- 13:48Speaker 3: different class, I'd argue, from any other food sensitivity test
- 13:51Speaker 3: on the market, because what we're now doing is we're
- 13:53Speaker 3: giving the provider a way of working out what's going
- 13:57Speaker 3: on from a gut health, so an immune health perspective,
- 14:00Speaker 3: and what's going on from an inflammatory perspective with our
- 14:03Speaker 3: food sensitivit attest. So again, in terms of you know
- 14:06Speaker 3: what sets us apart, that combination puts US, I would
- 14:10Speaker 3: say worlds apart from everyone else because again it's that
- 14:13Speaker 3: dynamic combination of the two which is where a lot
- 14:17Speaker 3: of the good practitioners work and we're very fortunate that
- 14:20Speaker 3: we work with a lot of those well.
- 14:22Speaker 1: And so you said two things. One is you said
- 14:24Speaker 1: your test is the only one that's patented. What kind
- 14:27Speaker 1: of pattern do you have?
- 14:29Speaker 3: So it's around those multiple pathways, so to say the
- 14:31Speaker 3: reality is rather than just having a pattern which looks
- 14:34Speaker 3: at one pathway, it's that combination of pathways, which is really,
- 14:39Speaker 3: as I mentioned, where the magic begins, because it gives
- 14:41Speaker 3: us a way of rather than just isolating a pathway,
- 14:46Speaker 3: the reality of everything in life. It's more complex than
- 14:48Speaker 3: just a single answer. If it wasn't, then probably none
- 14:50Speaker 3: of us would have a business, and more important, we'd
- 14:52Speaker 3: all be able to take care of our own health.
- 14:54Speaker 3: In essence, it's that combination of elements that work together,
- 14:58Speaker 3: and that's why.
- 14:59Speaker 4: We look at those multi pathways with the food sensitivities, and.
- 15:03Speaker 3: Also why we look at the combination of immune health
- 15:07Speaker 3: with the barrier panel as well as inflammation with our
- 15:12Speaker 3: food sensitivity test and lay it on as we just
- 15:14Speaker 3: discussed the environmental elements by looking at those colorings and
- 15:18Speaker 3: additives to really try and get to the crux of
- 15:20Speaker 3: what might be going on and as importantly, what might
- 15:23Speaker 3: be causing those symptoms that the patients present with.
- 15:27Speaker 2: You also said.
- 15:28Speaker 1: That now that's very helpful, James. You also said that
- 15:33Speaker 1: your test is so simple. It's a blood test, I mean,
- 15:36Speaker 1: and you can do it in your home, which is
- 15:39Speaker 1: very different than the typical microbiome testing, which is usually
- 15:43Speaker 1: stool testing and us.
- 15:45Speaker 2: You can do it in your home, but it's not
- 15:47Speaker 2: much your fun exactly.
- 15:49Speaker 1: So what is it that makes your blood tests as
- 15:53Speaker 1: or more efficacious than the typical stool tests?
- 15:58Speaker 4: Sure, so we do. We'll talk a little b about
- 16:02Speaker 4: the GUP barrier parents.
- 16:02Speaker 3: So there's four key markers on there, and there's a
- 16:05Speaker 3: couple of pathways that we measure.
- 16:07Speaker 4: And so the four markers are CANDIDA.
- 16:11Speaker 3: Including an LPs, and I'll go into a little bit
- 16:13Speaker 3: of detail on each one of them without I'm glad.
- 16:17Speaker 2: I'm glad you because I want you to define each.
- 16:19Speaker 4: One for exactly. I will. I will so a.
- 16:22Speaker 1: Picture of the test if you have one handy that.
- 16:25Speaker 3: They can bring that up as well, so we can
- 16:28Speaker 3: show we can show everyone what the what what we're
- 16:31Speaker 3: talking about, talk about.
- 16:33Speaker 1: Mars yesh like I did in at the A four
- 16:37Speaker 1: M a couple of years ago. What what does it
- 16:40Speaker 1: look like and what are.
- 16:42Speaker 4: The I just need you to let me.
- 16:46Speaker 3: Screen share, that's fine, that's fine, and I'll bring that
- 16:51Speaker 3: panel up and to your point. Hopefully they will make
- 16:53Speaker 3: it a bit clearer to people in terms.
- 16:55Speaker 1: Of what go back to the school test, because I
- 16:57Speaker 1: think people really want to know.
- 16:59Speaker 2: How can I avoid It's.
- 17:02Speaker 1: So easy, it's just prick, pricking my finger and getting.
- 17:09Speaker 3: I don't I don't know if Jamie are editor in chief,
- 17:11Speaker 3: can help us get into that. But says host disabled
- 17:15Speaker 3: participant screen sharing. So maybe it's at the bottom of
- 17:17Speaker 3: your screen there.
- 17:18Speaker 1: Okay, Jamie if you can, oh, he says, can you
- 17:23Speaker 1: can you see what he's saying?
- 17:25Speaker 2: Can you email a picture?
- 17:27Speaker 3: Yeah? I can find it. I'm not sure. Picture here,
- 17:33Speaker 3: let go, we'll go live. I will take a picture
- 17:36Speaker 3: of it now and then we'll send it. So that'll
- 17:38Speaker 3: be I think that's described as multimedia, isn't it. So
- 17:43Speaker 3: we'll get we'll get that so everyone, and I think
- 17:46Speaker 3: it's definitely worth showing because again I think it will
- 17:48Speaker 3: show people exactly what we're talking about, which I think
- 17:51Speaker 3: is helpful.
- 17:52Speaker 6: Exactly Jamie, So he's got that. So is that email again, Jamie,
- 18:02Speaker 6: bring that up.
- 18:04Speaker 4: To t sweet. Here we gain. I won't repeat it.
- 18:07Speaker 4: Here we go and we'll get this out to you.
- 18:10Speaker 3: But I think it's really helpful to show people a
- 18:12Speaker 3: the different pathways that we're looking at. But more importantly,
- 18:16Speaker 3: I think the four different elements that we've included, which
- 18:19Speaker 3: I think will be really make it a lot more
- 18:22Speaker 3: sense than we've got.
- 18:24Speaker 2: Now, you know, most people, I mean most people know
- 18:28Speaker 2: you say.
- 18:28Speaker 1: Candida, and we Americans, I think, say Candida. But whichever
- 18:33Speaker 1: way Candida or Candida, most people know what that is.
- 18:38Speaker 2: I don't think a lot of.
- 18:39Speaker 1: People know what zonulin including and LPs are, and so
- 18:45Speaker 1: those markers are really important to understanding the results of
- 18:48Speaker 1: your task. So that's why I wanted people to have
- 18:51Speaker 1: a visual if you can, if it can work, If not,
- 18:54Speaker 1: we'll just.
- 18:54Speaker 2: Talk about it.
- 18:55Speaker 3: But yeah, yeah, no problem. I think that's a great idea.
- 18:57Speaker 3: So hopefully hopefully Jamie will have that and he'll help
- 19:00Speaker 3: bring that up on screen. To your point, the other
- 19:02Speaker 3: nice thing about what we're doing there is we're looking
- 19:05Speaker 3: at a couple of pathways, So we're looking at the
- 19:07Speaker 3: IgG in the complement, which obviously we do with our foods,
- 19:09Speaker 3: which we were just discussing earlier, but we've also added
- 19:12Speaker 3: I think on IgA one and two because IgA is
- 19:15Speaker 3: a secretory marker which generally indicates it's found localized in
- 19:20Speaker 3: the gut. So we want to look at those four
- 19:22Speaker 3: markers from is it in the gut or has it
- 19:24Speaker 3: become more systemic, And if it's become more systemic, generally
- 19:27Speaker 3: what you'll see is the IgG and the C three
- 19:30Speaker 3: D elevated. So again that's why we want to look
- 19:33Speaker 3: at those multiple pathways to see is an early stage,
- 19:36Speaker 3: so that helps to provide and work out what they
- 19:38Speaker 3: need to do. It's early stage or is it later stage?
- 19:41Speaker 3: I'm more systemic, have been going around for a longer
- 19:45Speaker 3: time period. So hopefully I haven't seen Jamie response. It's
- 19:51Speaker 3: got to go all the way from Boston to California
- 19:53Speaker 3: on the on the super Highway. Hope there's no there's
- 19:57Speaker 3: no accidents on the super Highway today.
- 20:00Speaker 4: Uh, let me.
- 20:02Speaker 1: Jamie. Are you okay about getting a visual up for us?
- 20:09Speaker 1: Just waiting for the email? So the email hasn't gone through.
- 20:15Speaker 3: Wow, anyway, So you've got as I said, we've got
- 20:19Speaker 3: these two pathways and we'll talk about those four markers.
- 20:21Speaker 3: So we use Canada as an indicative there may well
- 20:24Speaker 3: be some early stage just bys this going on, so
- 20:27Speaker 3: things beginning to occur that we'd want to avoid. And
- 20:31Speaker 3: then to your point, Michelle, we talk about those two
- 20:33Speaker 3: markersulin and occluding and they're talking about those tight junctions
- 20:38Speaker 3: that exist between your gut and your blood system. So
- 20:41Speaker 3: you want to make sure that they're opening and closing appropriately,
- 20:45Speaker 3: and so zguline is a great indicator of how well
- 20:50Speaker 3: those are functioning. And so we were very fortunate to
- 20:52Speaker 3: work with what I describe as the as the dream
- 20:56Speaker 3: team of doctor Alessios of Bazzano who just covered sonulin
- 21:00Speaker 3: and its links with sealyact disease. And then also our
- 21:05Speaker 3: very own Dr Brent Dorbel, who invented the cab mot
- 21:08Speaker 3: fit test and he his not insignificant claim to fame
- 21:12Speaker 3: was he invented the first rapid HIV test as well,
- 21:15Speaker 3: So again a brilliant, brilliant man. Both of those are brilliant,
- 21:18Speaker 3: brilliant scientists. And again what we wanted to use is
- 21:21Speaker 3: they're combined know how to develop this sonulent.
- 21:24Speaker 4: Test, and that's what they did for us. And so
- 21:27Speaker 4: it's a.
- 21:28Speaker 3: Unique recombinant donuline antibody that we've developed which enables us
- 21:32Speaker 3: to measure that sonulin, which tells you how well those
- 21:35Speaker 3: tight junctions are functioning. And then we also developed with
- 21:39Speaker 3: our team was a the occluding marker, which tells you
- 21:45Speaker 3: structurally are they still together or they're beginning to come apart.
- 21:48Speaker 3: So it's almost level one Canada, level two zulin level
- 21:52Speaker 3: three occluding And so the neat thing about that zulin marker,
- 21:59Speaker 3: not wanting to keep circling back to stall, but again
- 22:02Speaker 3: important to kind of highlight that zonulin was developed or
- 22:06Speaker 3: discovered by doctor Alesio Pizzano. And when I asked him
- 22:09Speaker 3: should that be a stall or a blood test, he
- 22:12Speaker 3: told me, said, James, all my seminal research was done
- 22:16Speaker 3: on the zangulin in blood. So on the basis it
- 22:18Speaker 3: was good enough for him and his papers that have
- 22:22Speaker 3: been published in the Lancet and other major journals, we
- 22:25Speaker 3: wanted to kind of mirror his work. And that's really
- 22:27Speaker 3: what we see now in terms of the prevalence in
- 22:32Speaker 3: terms of the patient population with the WE measure is
- 22:36Speaker 3: very similar to the data he had published in the
- 22:38Speaker 3: Lancet back in early two thousands. Some we'veere very good
- 22:41Speaker 3: about the quality of that marker, and again that's a
- 22:44Speaker 3: unique market to KBMO, so we have the only patented
- 22:47Speaker 3: food senscivity test, and we have this unique zangulin that
- 22:51Speaker 3: is not available to anyone else in the marketplace. And
- 22:54Speaker 3: again because it's so good that avoids people having to
- 22:57Speaker 3: do the stall test, or at least understanding by doing
- 23:00Speaker 3: this panel that we talk about do they have to
- 23:02Speaker 3: go on and do the stall test or not because
- 23:04Speaker 3: a lot of the markers are elevated, then you may
- 23:07Speaker 3: feel like that that you could be reflexed onto a
- 23:10Speaker 3: stall test at that point.
- 23:12Speaker 2: And what about LPs the language.
- 23:14Speaker 4: Just coming to that now.
- 23:15Speaker 3: So LPs is short for a thing called LiPo polysaccharides,
- 23:19Speaker 3: which again is one of these markers that we talked about,
- 23:22Speaker 3: leaky gut, leaky brain. Lots of links between brain health
- 23:26Speaker 3: and gut health linked with lipopolysaccharides. It's also another indicator
- 23:32Speaker 3: of the innate immune system. And so we mentioned the
- 23:35Speaker 3: innate immune system with the C three D marker. That's
- 23:38Speaker 3: the second pathway that we measure. And so again we're
- 23:41Speaker 3: strongly identifying on that side of the fence as well.
- 23:44Speaker 3: So not just exposure, and it was it's been nicknamed
- 23:49Speaker 3: by that good friend of ours at the company's Dr
- 23:51Speaker 3: Rob Silverman, is l Diablo. So Basically, if you've got
- 23:55Speaker 3: elevated LPs, that's indicative that a number of the gram
- 23:58Speaker 3: negative bacteria that may be present in your gut inflaming
- 24:02Speaker 3: you and causing you issues.
- 24:04Speaker 4: So again, if.
- 24:05Speaker 3: That's elevated, that's great information to know and may then
- 24:09Speaker 3: lead on to going.
- 24:09Speaker 4: To do a stall test to require.
- 24:11Speaker 3: But again, if all those markers are a negative, you
- 24:15Speaker 3: don't necessarily I would say that probably be gives you
- 24:17Speaker 3: are pretty good way of avoiding.
- 24:19Speaker 4: Having to do a stall test.
- 24:20Speaker 3: If they're positive, then you might want to consider it
- 24:23Speaker 3: based on the provider you work with and what our
- 24:26Speaker 3: providers say. So on the bottom of our report we say,
- 24:29Speaker 3: if any of these eight markers are positive, then we
- 24:33Speaker 3: recommend you consult your provider with regards a good gut
- 24:37Speaker 3: healing protocol.
- 24:37Speaker 4: And so that's the advantage.
- 24:39Speaker 3: Of doing this test is we can identify what might
- 24:42Speaker 3: be going on from a tight junction perspective. I do
- 24:46Speaker 3: you have leaky gut or not? Is there any early
- 24:49Speaker 3: indication of this biasis. Can we get to it ahead
- 24:51Speaker 3: of time with the candida market, or has it got
- 24:55Speaker 3: more severe and the LPs is elevated by that lifeboat
- 24:59Speaker 3: polysaccharis kind of kicking off as well, and life popoly
- 25:02Speaker 3: sacrifice is linked to many different things. We've talked about
- 25:04Speaker 3: brain cardiovascular health as well, so again another one of
- 25:08Speaker 3: those important markers, xilolins also linked with cardiovascular health. So
- 25:12Speaker 3: again you want to make sure that you know we're
- 25:15Speaker 3: measuring these markers and for the positions that we work with,
- 25:19Speaker 3: not a huge surprise that they recognize the interactions between
- 25:22Speaker 3: all these different things, so you don't just go and
- 25:25Speaker 3: see a gas trentrologist. That's the beauty of these functional
- 25:28Speaker 3: medicine type providers that we work with. They're looking at
- 25:31Speaker 3: the patient in the whole versus just identifying individual elements.
- 25:35Speaker 3: So I think that's the great thing with functional medicine
- 25:38Speaker 3: and the providers that we work with a they're some
- 25:41Speaker 3: of the best of the best, but more importantly, they're
- 25:44Speaker 3: looking at you as a whole versus individual organ by
- 25:48Speaker 3: organ given that's not how your body works. The reality
- 25:51Speaker 3: is your body is interconnected. All these things are working together.
- 25:55Speaker 3: So the idea is great to work with providers who
- 25:58Speaker 3: understand that versus a to maybe just one area of
- 26:01Speaker 3: your body. Given the interactions and the fact that all
- 26:04Speaker 3: these markers are linked through the research with you know,
- 26:08Speaker 3: having an impact in a number of different concepts and
- 26:10Speaker 3: areas as well.
- 26:12Speaker 1: What I think has happened over the last few years
- 26:15Speaker 1: is the microbione has taken a front seat to so
- 26:19Speaker 1: many of the discussions about your overall health. And this,
- 26:23Speaker 1: of course is really good for you and that you're
- 26:27Speaker 1: providing solutions to people who are facing that the deterioration or.
- 26:34Speaker 2: The damage of their microbione.
- 26:36Speaker 1: And it seems like almost like there isn't a person
- 26:40Speaker 1: alive that does not have a microbione issue one way
- 26:44Speaker 1: or the other, whether it's leaky gut or candido or
- 26:47Speaker 1: you know. So, you know, we could go into all
- 26:50Speaker 1: the reasons why. I think everybody knows it's a you know,
- 26:54Speaker 1: a society has gone awry with respect to choices, and
- 26:59Speaker 1: this is just too many bad choices and too many
- 27:01Speaker 1: people that are susceptible to whether they don't have the
- 27:05Speaker 1: proper information or they just don't care, but they make
- 27:09Speaker 1: the choices that are damaging to them if they wanted,
- 27:12Speaker 1: If somebody wants to back up a little bit first
- 27:15Speaker 1: and find out if they are inflamed just by looking
- 27:18Speaker 1: at their blood. Is the CEA reactive protein tests the
- 27:22Speaker 1: tests that you recommend. I know that's used for cardiovascular health,
- 27:26Speaker 1: but it's also usually.
- 27:28Speaker 4: Absolutely I mean, that's a great one.
- 27:30Speaker 3: And actually we also have a we're just developing a
- 27:32Speaker 3: cardiovascular inflammation test, and high sea reactive protein is one
- 27:38Speaker 3: of the markets we've included because again talking about those interactions,
- 27:42Speaker 3: we did a clinical study look at IBS and patients
- 27:45Speaker 3: in the Greater La Area, Los Angeles area about ten
- 27:49Speaker 3: years ago now, and we measured high sense to CRP
- 27:54Speaker 3: as well as triglycerides and home sustein levels and what
- 27:59Speaker 3: we saw took a hundred patients.
- 28:00Speaker 4: It was an IRB A.
- 28:01Speaker 3: Pre study, and we saw in the intervention group a
- 28:05Speaker 3: dramatic reduction in symptoms when they eliminated the foods that
- 28:09Speaker 3: we've identified on the on the food inflammation test. But
- 28:13Speaker 3: also we saw their CRP, so the high sense of
- 28:16Speaker 3: CRP a general as you point out, cardiovasculate inflammatory marker
- 28:21Speaker 3: came down precipitously as well.
- 28:23Speaker 4: As homo sesteine levels as well.
- 28:25Speaker 3: So again that really talks to those inter relationships that
- 28:29Speaker 3: I was kind of mentioning earlier. If you've got leaky
- 28:32Speaker 3: gut or you've got IBS you then, and you're also
- 28:36Speaker 3: dealing with high levels of CRP so C reactive protein
- 28:40Speaker 3: as well as elevated Homo susteine levels. If you can,
- 28:45Speaker 3: if you can help heel that gut, then good things
- 28:48Speaker 3: happen across the system, so it's not isolated to just
- 28:51Speaker 3: one thing. And so again back to you know, Hipocrates
- 28:54Speaker 3: from obviously quite a while ago now saying that all
- 28:58Speaker 3: that disease starts in the gut. So if you can
- 29:00Speaker 3: heal that gut, then you're in a really strong position
- 29:03Speaker 3: to look at your overall health. And I think the
- 29:05Speaker 3: great thing about this path it's identifying a handful of food,
- 29:09Speaker 3: so it's not overwhelming. And the other nice thing sometimes
- 29:13Speaker 3: you see these reports of twenty thirty pages. Again you've
- 29:16Speaker 3: got to maybe be a PhD and maybe even higher
- 29:20Speaker 3: to kind of understand some of these things. So the
- 29:22Speaker 3: idea about how we present the information to back to
- 29:24Speaker 3: patients and providers is simple. We want it to be
- 29:28Speaker 3: approachable because at the end of the day, if a
- 29:30Speaker 3: patient cannot understand the report and what it's telling you,
- 29:34Speaker 3: then we've lost. Because what we want to do is
- 29:37Speaker 3: we want our patients to be compliant, because again, if
- 29:40Speaker 3: they're not compliant, then we're all kind of wasting our time, frankly.
- 29:43Speaker 3: So the idea here is how do we, with good
- 29:46Speaker 3: science make sure we present data in a format that
- 29:50Speaker 3: is approachable and understandable for patients. And so a good
- 29:55Speaker 3: example of that is our report is intentionally short. It's
- 29:58Speaker 3: not because we don't have got we've out of things
- 30:00Speaker 3: to say after three pages. The idea is, let's keep
- 30:03Speaker 3: it short so you the patient can see the foods
- 30:06Speaker 3: you need to eliminate, and it's easy for the provider
- 30:09Speaker 3: to interpret as well. And the gut barrier panels is
- 30:12Speaker 3: on that three page report as well, so that's really
- 30:15Speaker 3: key to us to make sure it's simple and easy
- 30:17Speaker 3: to understand. And we've also now added a food app,
- 30:21Speaker 3: so and applicate an app.
- 30:22Speaker 4: So you can get those results on your phone.
- 30:24Speaker 3: Because again, twenty years ago, you'd be able to kind
- 30:27Speaker 3: of come back from seeing your physician. You could stick
- 30:31Speaker 3: your results on a magnetic fridge and you'd be in
- 30:33Speaker 3: great shape. Unfortunately, those fridges aren't very magnetic anymore. And
- 30:37Speaker 3: nowadays everyone's got a smartphone, so let's put that information
- 30:40Speaker 3: on their phone so if you're grocery shopping, you've got
- 30:43Speaker 3: access to it. If you're out for dinner with friends,
- 30:46Speaker 3: you've got access to it and you can show them,
- 30:48Speaker 3: or if you're in a restaurant, you can show the
- 30:50Speaker 3: way to look. These are the foods I need to
- 30:52Speaker 3: eliminate or not eat when I'm here? Can you help
- 30:55Speaker 3: me with my with my choices of what I'm going
- 30:58Speaker 3: to consume tonight. Neat thing we've done is we've provided
- 31:01Speaker 3: a meal plan because again, we want to make sure
- 31:04Speaker 3: that whatever journey a patient is on, that they've got
- 31:07Speaker 3: the information and the tools that can help them be successful,
- 31:11Speaker 3: because they say, that's the key for what we do.
- 31:14Speaker 3: We want patients to be successful. So let's give them
- 31:17Speaker 3: some tools versus going here's a report, good luck with
- 31:20Speaker 3: that our approaches, let's how do we give you, the
- 31:23Speaker 3: patient and the providers tools to garret to kind of
- 31:27Speaker 3: enhance the likelihood of a patient being successful with whatever
- 31:31Speaker 3: that outcome they're looking for on their overall health journey.
- 31:35Speaker 1: What we could call a normal homo sistine level.
- 31:41Speaker 4: That's a great question.
- 31:42Speaker 3: I'll get back to you on that in terms of
- 31:43Speaker 3: what we consider normal on that again, that can vary,
- 31:47Speaker 3: so again we can confirm that, but definitely what we
- 31:51Speaker 3: saw on the study that we ran was a great
- 31:53Speaker 3: reduction in that homelessestein and the CRP level. So it
- 31:56Speaker 3: was really exciting because we talk about having a fee
- 32:00Speaker 3: inflammation test, and again h CRP, as you mentioned, Michelle,
- 32:05Speaker 3: is one that all physicians from any walk of life
- 32:09Speaker 3: would would understand as a true marker of inflammatory response.
- 32:13Speaker 3: So the fact that we saw that decline I think
- 32:16Speaker 3: is really interesting. And the fact that it was an
- 32:18Speaker 3: IBS population not maybe a more classical cardiovascular population, I think,
- 32:24Speaker 3: as I say, it speaks to that interaction between the
- 32:27Speaker 3: various markers and the various systems in your body.
- 32:31Speaker 1: Right, And then why did you see ALYSSA test? What
- 32:34Speaker 1: I know that's kind of the grandfather, right.
- 32:36Speaker 3: Of the food allergy is a type of technology which
- 32:41Speaker 3: has been broadly adapted across many, many countries now and
- 32:45Speaker 3: so one of the reasons we've we've applied it because
- 32:48Speaker 3: again we have labs now in Mexico, Brazil, one in Shanghai,
- 32:52Speaker 3: one a place called Chain Deo, and obviously our own
- 32:53Speaker 3: here in Boston, Massachusetts. And so again it's a it's
- 32:57Speaker 3: a relatively straightforward, highly robust technology that you can implement
- 33:02Speaker 3: in many different parts of the world. So our view is,
- 33:05Speaker 3: let's not necessarily have a five hundred thousand dollar piece
- 33:07Speaker 3: of kit for labs to try and set up themselves.
- 33:12Speaker 3: Let's make sure we have a technology that is highly
- 33:15Speaker 3: robust that can then be an affordable to make sure
- 33:19Speaker 3: that we can share the lovers that we're all around
- 33:22Speaker 3: the world of the tests and technologies that we do,
- 33:25Speaker 3: rather than make them prohibitively expensive for people to get
- 33:29Speaker 3: involved in it. And that's both at the provider as
- 33:33Speaker 3: well as patient level. So we've intentionally tried to make
- 33:35Speaker 3: sure we keep things affordable.
- 33:38Speaker 4: And that's one of the great examples of that.
- 33:39Speaker 3: Let's use the most robust technology out there, which is Eliza,
- 33:43Speaker 3: and the other nice thing with KBMO is we not
- 33:47Speaker 3: only have the test, but we manufacture those Eliza tests
- 33:50Speaker 3: as well, so we control the entire value chain. So
- 33:53Speaker 3: that's really important because again we're looking at up to
- 33:57Speaker 3: one hundred and seventy six different foods, colorings, and narratives
- 34:00Speaker 3: and the eight markers that we just described on that
- 34:02Speaker 3: gut barrier panel. We are passionate about making sure those
- 34:06Speaker 3: results are accurate, and the best way you can ensure
- 34:09Speaker 3: of those things is controlling all those things yourself. And
- 34:12Speaker 3: so that's one of the things we've done as an
- 34:13Speaker 3: organization is rather than leave those things to chance, let's
- 34:17Speaker 3: make sure we control all that enhance the performance of
- 34:21Speaker 3: the testing. A great example of that, again is one
- 34:25Speaker 3: of the reasons I think we're so accurate is because
- 34:28Speaker 3: our founder with is infect disease I measuring HIV back
- 34:33Speaker 3: in the day. We use fifteen standards and controls for
- 34:36Speaker 3: patient to enhance to make sure it's not only very reproducible,
- 34:41Speaker 3: but also it's highly accurate. And again, I think that's
- 34:44Speaker 3: been one of the knocks on some of these tests
- 34:46Speaker 3: historically is that they've not always been accurate.
- 34:48Speaker 4: So again that's the great thing about what we do.
- 34:51Speaker 3: All our manufacturing is under FDA in an FDA registered
- 34:56Speaker 3: manufacturing facility, and all the tests are run under in
- 34:59Speaker 3: a clear high complexity labs. So again, all these things
- 35:02Speaker 3: are monitored, which we love because again that enhances and
- 35:06Speaker 3: ensures the accuracy of the testing that we perform.
- 35:10Speaker 1: You know, the other thing too, is that being vertically integrated.
- 35:14Speaker 1: You know, you don't rely on the Chinese or the
- 35:17Speaker 1: supply chain that's been so damaged in the last few years.
- 35:22Speaker 1: And absolutely yeah, So that effects not only the efficacy
- 35:27Speaker 1: the quality, but also the price and the time that
- 35:31Speaker 1: you have to respond to the patient because of the
- 35:37Speaker 1: fact that you're controlling all of the different processes that
- 35:41Speaker 1: go along into the measurement. So I think that's a
- 35:44Speaker 1: really big uniqueness about you.
- 35:47Speaker 3: Anything we buy from excellentally is from a big US manufacturer.
- 35:52Speaker 3: During COVID they were having issues. We went, we drove
- 35:54Speaker 3: to the plant in Maine to pick up the product.
- 35:56Speaker 3: So again we are not shy to get off our
- 36:00Speaker 3: behind some kind of fixed problems. So again we are
- 36:03Speaker 3: making sure that that was the only thing that we
- 36:05Speaker 3: didn't have. Now we stop well over twelve months supply
- 36:08Speaker 3: of that one product that was the only thing we
- 36:10Speaker 3: weren't consuming or manufacturing.
- 36:12Speaker 1: Rather, you're still a private company, correct, we are.
- 36:16Speaker 2: I actually approached by a lot of the big.
- 36:19Speaker 3: Guys exactly, and I think you know, but the beauty
- 36:22Speaker 3: of being private is we can invest heavily in R
- 36:25Speaker 3: and D as we're doing and looking after our people,
- 36:27Speaker 3: which again is an old fashioned approach, but we think
- 36:29Speaker 3: it's really important that you know, we look after the
- 36:32Speaker 3: people that work for us, they do an amazing job
- 36:34Speaker 3: with very and I always say it's a great position
- 36:37Speaker 3: of fortune that we're in that we can employ people.
- 36:40Speaker 4: So if people choose.
- 36:41Speaker 3: To work for us, we want to make sure we
- 36:42Speaker 3: do the best that we possibly can for them. I'd
- 36:45Speaker 3: argue that's not something if you work for a financial
- 36:48Speaker 3: financially backed organization that they would say the same thing.
- 36:51Speaker 3: So again, the fact that we're family run and on
- 36:54Speaker 3: is very very important to me because again it means
- 36:57Speaker 3: we can we can, we can be Johnny on the spot,
- 37:00Speaker 3: we can do whatever we need to support our providers
- 37:02Speaker 3: in terms of getting and test results or whatever other
- 37:04Speaker 3: questions they may have. And that is we're very passionate,
- 37:07Speaker 3: passionate about that. We don't look at well, is that
- 37:11Speaker 3: going to be cost effective to pick up the phone
- 37:13Speaker 3: and speak to Michelle on a Sunday. We don't care
- 37:15Speaker 3: about that because we're privately owned and we're going to
- 37:18Speaker 3: make sure we do the very best for all our clients.
- 37:21Speaker 4: We're not led by shovels.
- 37:22Speaker 3: We're led by making sure we're passionate about doing the
- 37:26Speaker 3: right job for all our clients and all our supplies
- 37:30Speaker 3: and more importantly all our employees as well.
- 37:33Speaker 1: Well, you know, I have a little remiss in not
- 37:35Speaker 1: doing what I normally do at the beginning of every podcast,
- 37:39Speaker 1: probably because you were on my podcast previously, and that
- 37:42Speaker 1: is asking you about your journey to where you are today.
- 37:46Speaker 1: So let me just give a quick thumbnail so I
- 37:50Speaker 1: don't interrupt our flow here because we're really into the
- 37:53Speaker 1: reads of the product. But the reason I'm interrupting right
- 37:58Speaker 1: now is because James, Well, first, everybody can tell you
- 38:02Speaker 1: from I think everybody can tell where you come from,
- 38:05Speaker 1: and that voices our wonderful ally across the pond Great Britain.
- 38:10Speaker 1: And although we were having a conversation at Radfest this weekend,
- 38:16Speaker 1: I was there for the for the Health Convention, as
- 38:20Speaker 1: one of the topics was because there were some British
- 38:23Speaker 1: people there is how do you tell the difference between
- 38:26Speaker 1: Great Britain, South Africa, Australia and what was the other one?
- 38:34Speaker 2: New Zealand?
- 38:35Speaker 1: Of course, and so you know, people were saying that
- 38:37Speaker 1: it's really and then I asked them can they tell
- 38:40Speaker 1: that the one guy was from near London? I said,
- 38:44Speaker 1: can you tell the different dialect when you come to
- 38:47Speaker 1: the US. So anyway, so it is kind of difficult
- 38:49Speaker 1: for us. For me, I oftentimes confuse someone from Australia,
- 38:54Speaker 1: although they are far more dasled than the Great Great Britain.
- 38:59Speaker 1: But but South Africa, I do have some difficulty differentiating.
- 39:05Speaker 1: But anyway, not to get into that subject, just it's
- 39:08Speaker 1: kind of humorous. But you obviously have been here for many,
- 39:13Speaker 1: many years and came here having been with big corporations
- 39:16Speaker 1: and came here with a big corporation and then, as
- 39:19Speaker 1: often happens with entrepreneurs, who have their training with the
- 39:23Speaker 1: big companies and then morph into the entrepreneurial world. But
- 39:28Speaker 1: in between there you were with venture capital companies. And
- 39:33Speaker 1: so the fact that you're not you didn't turn to
- 39:36Speaker 1: venture capital for KBMO, I think is a.
- 39:40Speaker 2: Much more.
- 39:42Speaker 1: Compelling point here, given that you had all the contacts
- 39:46Speaker 1: and could have gone that way. But of course, when
- 39:48Speaker 1: you're going that way with the investor philosophy of the
- 39:53Speaker 1: venture capital world, you know, you do potentially you lose
- 39:57Speaker 1: a lot of control.
- 39:58Speaker 3: And I think the other point is they all have
- 40:01Speaker 3: funds and they have to kind of you know, their
- 40:03Speaker 3: master to you know, other financial institutions, and so that
- 40:07Speaker 3: timing may not necessarily work with what makes sense for
- 40:09Speaker 3: us as an organization. And so my view, having seen
- 40:12Speaker 3: that happen, much better to take control of your own
- 40:15Speaker 3: destiny and do it the right way, and that gives
- 40:17Speaker 3: us an ability to have a much longer term view
- 40:21Speaker 3: and enable us to be vertically integrated, because we're going
- 40:23Speaker 3: to look, you know, we own this business already for
- 40:25Speaker 3: over ten years, which would be heresy in the venture
- 40:28Speaker 3: capital world, whereas we're just starting after ten years. You know,
- 40:31Speaker 3: we're you know, we're I always joke we're an overnight
- 40:34Speaker 3: success after ten years. So it's one of those things
- 40:37Speaker 3: where you know, if you can take a long term view,
- 40:41Speaker 3: generally the outcomes will be much much more beneficial versus
- 40:45Speaker 3: kind of, you know, constantly being in a flip mode,
- 40:47Speaker 3: which I think a lot of these financial places are.
- 40:49Speaker 3: They try and quickly bolt things together so they can
- 40:52Speaker 3: get to whatever scale really means, so they can flog
- 40:55Speaker 3: the thing. On our view is build it the right
- 40:58Speaker 3: way organically and make sure as we add stuff it'll
- 41:01Speaker 3: be as we are world class. And so again they
- 41:04Speaker 3: don't have that luxury because they're always in a hurry
- 41:06Speaker 3: to rush to nowhere. Our view is make sure you
- 41:09Speaker 3: take your time, you do it right, and if you
- 41:12Speaker 3: do that, then you know you'll have long term success.
- 41:14Speaker 3: And we're very fortunate that's where we're at.
- 41:17Speaker 1: Well that that actually brings up a very good point
- 41:22Speaker 1: and I'm getting a little bit off the track, but
- 41:24Speaker 1: it's important that we covered this.
- 41:26Speaker 2: Where are you going? Where do you think, what is
- 41:29Speaker 2: your exit strategy?
- 41:30Speaker 1: Where do you think you will be in the next
- 41:32Speaker 1: ten years.
- 41:33Speaker 3: So I think our view is, as I mentioned, we've
- 41:35Speaker 3: got the best food tends to Be tests in the world,
- 41:39Speaker 3: and that's a great place to be. But we've also
- 41:42Speaker 3: got over ten thousand providers. So our view is can
- 41:45Speaker 3: we add more world class tests? World class being the
- 41:48Speaker 3: emphasis versus just we're going to add stuff, And I
- 41:51Speaker 3: think that's our focus is to say how do we
- 41:54Speaker 3: add the best to the best.
- 41:55Speaker 4: So a good example of that would be Sonuline.
- 41:57Speaker 3: There was zonulin tests on the market that we're average,
- 42:00Speaker 3: and so we didn't want to settle for average. We
- 42:02Speaker 3: wanted to develop one ourselves. So it took us four years.
- 42:05Speaker 3: If I was in a public company, i'd probably been
- 42:07Speaker 3: fired for that. But in the kind of I think
- 42:10Speaker 3: the much better private world that I operate in, we
- 42:13Speaker 3: took our time and created the best of the best.
- 42:16Speaker 4: And so sometimes you know a gan chat isn't always right, and.
- 42:20Speaker 3: So you want to make sure you've got the longevity
- 42:23Speaker 3: to make sure you come up with the right products.
- 42:25Speaker 4: And that's what we've done.
- 42:26Speaker 3: And so you know, we've got the best gut barrier
- 42:29Speaker 3: pal in fact the world, the only gut barrier pound
- 42:31Speaker 3: on the world with the unique Siglin test. So again
- 42:35Speaker 3: that's another way of separating us from from from the competition.
- 42:40Speaker 3: And again I think what we've done with our cardiovascular
- 42:42Speaker 3: information tests same thing. It's another world class test that
- 42:46Speaker 3: we've added, and we're now looking at adding more tests
- 42:49Speaker 3: and we can you know, watch this space to continually
- 42:52Speaker 3: making sure that you know, we keep supporting our clients
- 42:55Speaker 3: in the best way we can and our patients and
- 42:58Speaker 3: our employees.
- 42:59Speaker 4: And our appliers.
- 43:00Speaker 3: So I think our view is if you look after
- 43:03Speaker 3: those stakeholders who we consider very important, then you know,
- 43:07Speaker 3: good things happen. And so we're very fortunate we have
- 43:09Speaker 3: a lot of great physicians who work with us and providers,
- 43:13Speaker 3: and so we're constantly working with them to find out
- 43:16Speaker 3: one of the next things that they would like to
- 43:18Speaker 3: add and so certainly that's how we created the gap,
- 43:21Speaker 3: barrypal was feedback from those individuals. When we went from
- 43:25Speaker 3: our FIT one point thirty two, which one hundred and
- 43:27Speaker 3: thirty two foods, colorings, and antitives to our FIT one
- 43:30Speaker 3: seventy six, we worked with just over three hundred providers
- 43:34Speaker 3: there to kind of find out from them what it
- 43:36Speaker 3: was did they want, versus saying, well, you know, we're
- 43:39Speaker 3: brilliant scientists will tell you what you want. That's not
- 43:41Speaker 3: our approaches. We're very fortunate we have some great clients,
- 43:44Speaker 3: and so we want to listen to them to understand
- 43:47Speaker 3: what they want and then do it in the right way,
- 43:50Speaker 3: which isn't necessarily a quarterly financial model. It may take longer,
- 43:54Speaker 3: and we're happy with that because what we want to
- 43:56Speaker 3: do is come up with the best of the best,
- 43:59Speaker 3: not cheap fast one because I've got to shut my
- 44:02Speaker 3: venture capital fund in three years or three months or.
- 44:05Speaker 4: Whatever it is. So our view is we want to do.
- 44:08Speaker 3: The best by our clients, best by our employees, best
- 44:12Speaker 3: by the patient, and best buy our supplies.
- 44:15Speaker 1: And you mentioned the food food allergens, but you didn't
- 44:21Speaker 1: mention the cosmetics, which I think is another point on
- 44:27Speaker 1: the three legged stool, food and.
- 44:31Speaker 2: Additives and then personal.
- 44:33Speaker 4: Hi for sure.
- 44:35Speaker 3: So those color examples, you see them in terms of
- 44:36Speaker 3: you know, we see number of those markers in terms
- 44:40Speaker 3: of that come up in those to your point, those cosmetics,
- 44:44Speaker 3: and so again, thinking of skin as another barrier if
- 44:47Speaker 3: anything's going on, you know, we see amazing results where
- 44:51Speaker 3: you know, patients have different psoriasis, other skin related issues.
- 44:56Speaker 3: The reality with a lot of those it's your body's
- 44:58Speaker 3: natural response of inflammatory response, and that's why you see
- 45:02Speaker 3: those things. And so again, if you can look at
- 45:04Speaker 3: someone's diet to work out what might be causing that,
- 45:08Speaker 3: then that's where I think, you know, you get these
- 45:10Speaker 3: really incredible results that we see and here on a
- 45:13Speaker 3: constant basis from our providers that you know, patients feel
- 45:16Speaker 3: great because they've we've identified some of these issues, things
- 45:19Speaker 3: like migraines another one that's another inflammatory response. We see
- 45:22Speaker 3: great outcomes with patients who have migraines. So again, think
- 45:26Speaker 3: of all these things which are leading from inflammation. Think
- 45:29Speaker 3: of you know, bone inflammation or inflammation, you know, arthritis,
- 45:35Speaker 3: All these things are linked to inflammation. We're in the
- 45:38Speaker 3: process of doing an autism study at the moment with
- 45:41Speaker 3: Purdue University. So we're very fortunate we're at the stage where,
- 45:45Speaker 3: again we're not looking to flip this business.
- 45:47Speaker 4: We're looking to expand it and look.
- 45:48Speaker 3: At ways of we can work with more people doing
- 45:51Speaker 3: more you know, clinical research to expand our capabilities and
- 45:56Speaker 3: the types of providers we work with. With the brain health,
- 46:00Speaker 3: we're seeing again we've been approached by a number of
- 46:02Speaker 3: neurologists now who see the links between leaky gut and
- 46:05Speaker 3: leaky brain, and so that's another whole area that again
- 46:08Speaker 3: we're very dominant in because again we have that gut
- 46:11Speaker 3: barrier panel that they'd probably like is to rename brain
- 46:15Speaker 3: barrier panel.
- 46:15Speaker 4: But that's fine.
- 46:16Speaker 3: So you know, those tight junctions, guess what, they're not
- 46:19Speaker 3: just in the gut, They're in the brain and they're
- 46:21Speaker 3: in other major organs. So I think, you know, we
- 46:24Speaker 3: feel very fortunate that we've invested and taken the time
- 46:27Speaker 3: to develop the best of the best tests which then
- 46:29Speaker 3: have application in a number of these areas. And I
- 46:32Speaker 3: think that's the great thing with our company is we've
- 46:35Speaker 3: got these opportunities and just making sure we do them
- 46:38Speaker 3: steadily and slowly and make sure we do it the
- 46:40Speaker 3: right way, on the basis of longevity and doing it
- 46:44Speaker 3: the right way versus looking for an exit as such.
- 46:47Speaker 1: And do you screen the providers that you know? Ten
- 46:50Speaker 1: thousand of them, that's a lot of providers and you're
- 46:52Speaker 1: going to only grow from here. So how do you
- 46:55Speaker 1: know that you're getting the best of the best when
- 46:58Speaker 1: you want.
- 46:59Speaker 2: A provider approach.
- 47:01Speaker 3: Well, we're very fortunate now a lot of them we're
- 47:03Speaker 3: coming to us in terms of they're being referred by
- 47:07Speaker 3: their colleagues and so that's always, you know, a a
- 47:09Speaker 3: very nice thing for us in terms of we're at
- 47:11Speaker 3: that stage of rather than pushing the kind of snowball
- 47:14Speaker 3: up the hill, it feels like it's coming down the
- 47:17Speaker 3: other side where we get those referrals and you know,
- 47:20Speaker 3: the spankly there's no more, no better indication of the
- 47:23Speaker 3: job you're doing, you know, when one of your clients
- 47:26Speaker 3: is referring you on to one of their colleagues as well.
- 47:29Speaker 4: And so that's where we see a lot of the business.
- 47:31Speaker 3: And then we are very fortunate to partner with some
- 47:35Speaker 3: great conferences, things like Institute of Functional Medicine my all
- 47:40Speaker 3: time favorite apoM. Again, the anti agent guys have done
- 47:42Speaker 3: an amazing job I think of cornering that market from
- 47:45Speaker 3: an education and conference perspective, and so we've been very
- 47:49Speaker 3: fortunate that in many regards those are screened for us
- 47:53Speaker 3: in terms of the types of providers who are looking
- 47:56Speaker 3: to go the extra mile and attend these types of
- 47:59Speaker 3: meetings where they're looking at, you know, recognizing that the
- 48:03Speaker 3: kind of current system is kind of broken, how can
- 48:06Speaker 3: they enhance medical care, how can they go the extra
- 48:10Speaker 3: yard for their patient? And I think those types of
- 48:12Speaker 3: organizations that we work with in terms of the conference
- 48:15Speaker 3: with a hand give us this great on trend access
- 48:18Speaker 3: to some of these, you know, world class type providers.
- 48:21Speaker 2: And I you know, of.
- 48:22Speaker 1: Course, I am a member of a four M and
- 48:24Speaker 1: I think they're the granddaddy of the functional medicine conferences.
- 48:31Speaker 1: Although I would say having just come back from Radfest,
- 48:35Speaker 1: which was one that I had never really attended or
- 48:38Speaker 1: thought of attending until the co founder was on my
- 48:41Speaker 1: podcast and encouraged me, so I would tell you that
- 48:44Speaker 1: that was actually a very interesting conference. It's much smaller
- 48:50Speaker 1: and focus, you know, more. Their their kind of niche
- 48:55Speaker 1: is immortality or living longer better. But of course, you
- 49:02Speaker 1: know that's what all of us want is you know
- 49:04Speaker 1: why we're you know, involved in all these functional medicine conferences,
- 49:10Speaker 1: But this one was the exhibitors. I think you would
- 49:13Speaker 1: have liked it because they get a chance to talk
- 49:17Speaker 1: more directly to the doctors and the consumers that are visiting.
- 49:23Speaker 1: Because it's a much smaller exhibitor hall than the thousand
- 49:27Speaker 1: of or so that you get at a four M,
- 49:29Speaker 1: so you do get a lot more attention. And James
- 49:32Speaker 1: Stroll was is the person that was on my podcast.
- 49:36Speaker 1: He you know, has been brilliant about bringing in some
- 49:40Speaker 1: of the very very top speakers. They would probably love
- 49:44Speaker 1: to have you as a speaker, and if you're ever interested,
- 49:47Speaker 1: I'd be.
- 49:47Speaker 3: Happy to connect with always trying to get the message
- 49:51Speaker 3: out to kind of interest.
- 49:53Speaker 1: You know, ten ten of the at least ten of
- 49:56Speaker 1: my podcast guests were there as speakers. So that that's
- 50:01Speaker 1: one a good a good validation for us. But it's
- 50:05Speaker 1: also that they know how to search out some of
- 50:08Speaker 1: the very best the way we do.
- 50:10Speaker 2: And uh, I think it would be uh.
- 50:12Speaker 1: And and actually I don't think there was anyone doing
- 50:15Speaker 1: microbion like you know, Kurnan Krishna, and you know he's
- 50:20Speaker 1: been just he wasn't there, and he's doing a lot
- 50:24Speaker 1: of new things having left microbion Labs as a as
- 50:28Speaker 1: a founder. So but people like that, you know, we're
- 50:33Speaker 1: visibly conspicuously missing.
- 50:37Speaker 2: So I think maybe there would be some reason.
- 50:39Speaker 4: Out that sounds an interesting one for sure.
- 50:41Speaker 3: And we're always looking for kind of new new avenues,
- 50:45Speaker 3: you know, as we continue to grow. But those competition
- 50:48Speaker 3: and those referrals seem to be you know, it's a
- 50:51Speaker 3: constant source for us at the moment, which is fantastic.
- 50:53Speaker 3: And I say, we're continually looking to grow and come
- 50:55Speaker 3: on great podcasts like this one. You know, it's it's
- 50:58Speaker 3: about getting the message out to you know, those interested
- 51:01Speaker 3: consumers and providers you who are looking at making that
- 51:04Speaker 3: next leap into you know, functional medicine and longevity.
- 51:09Speaker 2: Well and the other thing.
- 51:10Speaker 1: I think people need to know what are the most
- 51:12Speaker 1: common food allergies. And let's also I know in our
- 51:16Speaker 1: last podcast we did differentiate and you defined, but let's
- 51:20Speaker 1: do it again just in case people didn't see that
- 51:23Speaker 1: the differences of food allergies or just let's say allergies
- 51:29Speaker 1: and intolerances and sensitivity. So those three, I guess would
- 51:34Speaker 1: be the three legged stool of.
- 51:38Speaker 3: So let the mon severity probably so allergy is a
- 51:43Speaker 3: it's an immunological response, and the pathways is I think
- 51:46Speaker 3: called IG which some of most people have heard of.
- 51:49Speaker 3: And generally with an I G allergy response, it's instant.
- 51:54Speaker 3: So again it kind of happens immediately in generally the
- 51:59Speaker 3: symptoms of severe so things like prophylactic shop think bad
- 52:02Speaker 3: thing happened, Think you know, kiddo eating peanut boom, instant reaction,
- 52:06Speaker 3: and so generally with an allergy, it's pretty obvious what
- 52:10Speaker 3: you might have just consumed has has kind of led
- 52:13Speaker 3: to that, you know, that cause and effect type thing.
- 52:16Speaker 4: So it's kind of instant with.
- 52:20Speaker 3: A With the with the intolerance, what I would say
- 52:25Speaker 3: there's it's an inability to process something. So if you
- 52:28Speaker 3: think like a lactose intolerance, it's an inability to process.
- 52:33Speaker 3: And that's what a you know, that's what you're looking
- 52:35Speaker 3: at when when you talk about an intolerance, when you
- 52:39Speaker 3: look at a sensitivity, which is what we're measuring, it's
- 52:43Speaker 3: more it's like an allergy. It's both thill immnological reaction.
- 52:48Speaker 3: But the big difference is the timing because what you're
- 52:52Speaker 3: seeing is it can be delayed up to seventy two hours,
- 52:55Speaker 3: so it makes it much harder for a patient to
- 52:58Speaker 3: work out what they might have consumed in that seventy
- 53:01Speaker 3: two hour period is leading to the symptoms they're presenting with.
- 53:04Speaker 3: And those symptoms can be many invaried, And we talked
- 53:07Speaker 3: about brain health, gut health, skin related issues, migraines, all
- 53:13Speaker 3: these different symptoms, which again we like to think of
- 53:17Speaker 3: the root cause of all those being inflammation. Hence why
- 53:20Speaker 3: I think we're seeing the kind of traction that we do,
- 53:23Speaker 3: because we're not just looking at exposure. We're looking at
- 53:25Speaker 3: which foods cause you an inflammatory response. And so that
- 53:29Speaker 3: when you look at those three things, you've got the
- 53:31Speaker 3: allergy IgE, you've got the sensitivity IgG and with us
- 53:37Speaker 3: the complement, and it's that delayed nature of that which
- 53:40Speaker 3: makes it different. And again the symptoms is generally much
- 53:44Speaker 3: less severe. And thirdly, as I say, you've got the intolerance,
- 53:48Speaker 3: which is more as I say, an inability to process something.
- 53:52Speaker 3: And the best example, obviously for most people is lactose.
- 53:55Speaker 3: So again with the lactose intolerance, an inability to process
- 54:00Speaker 3: us is an immediate reaction with the IgE or the
- 54:02Speaker 3: delayed reaction with the food sensitivity.
- 54:06Speaker 2: You know, that makes yeah, absolutely, and.
- 54:08Speaker 1: I know that eggs and milk and wheat are the three.
- 54:12Speaker 4: Yeah.
- 54:12Speaker 3: In fact, we're always it's one of the things we're
- 54:15Speaker 3: looking to develop, is can you develop a rapid test
- 54:17Speaker 3: to look at the big three of eggs, milk, and
- 54:19Speaker 3: wheat and so again that's one of the things we're
- 54:22Speaker 3: looking at.
- 54:22Speaker 2: Yeah, exactly what I was going to ask you.
- 54:24Speaker 1: So you you you were a great mind sync alike exactly.
- 54:29Speaker 1: But in addition, and just just one side note on that.
- 54:32Speaker 1: You know, I recently just had a blood test done
- 54:35Speaker 1: with my doctor, just you know, the normal one year
- 54:38Speaker 1: physical exam blood test. But she's very, very thorough, so
- 54:42Speaker 1: you know, they did they took twenty vials of blood.
- 54:46Speaker 1: I know, the doctor of vampire.
- 54:48Speaker 2: I didn't think I was gonna have any blood left.
- 54:50Speaker 2: I walked out of there.
- 54:51Speaker 1: But anyway, I guess one of the tests she did
- 54:56Speaker 1: was they made it a little bit of a mistake.
- 54:58Speaker 1: She wanted some food sensitivity test that was in her toolkit,
- 55:05Speaker 1: but they took.
- 55:06Speaker 2: The wrong one.
- 55:07Speaker 1: But anyway, included in that one.
- 55:09Speaker 2: They said that I had a sensitivity to eggs.
- 55:12Speaker 1: But honestly, James I eat eggs all the time and
- 55:16Speaker 1: I never feel anything, not immediately or even delayed.
- 55:22Speaker 2: So what would that mean that.
- 55:24Speaker 4: Well, that's the classical thing that's happened to you, Michelle,
- 55:28Speaker 4: is that you met that they gave you an IgG test,
- 55:30Speaker 4: which all it tells you is exposure, doesn't tell you
- 55:33Speaker 4: about inflammation.
- 55:34Speaker 3: So I would confidently predict that you know that test
- 55:39Speaker 3: that you'll provide around a very thorough provider, I'm sure
- 55:43Speaker 3: obviously if if twenty VARs has anything to kind of
- 55:46Speaker 3: go by, so the idea would be they've just measured
- 55:50Speaker 3: what you're exposed to, and so you quite rightly have
- 55:52Speaker 3: identified that you eat a lot of eggs eggs, So
- 55:55Speaker 3: again that is the the I would argue limitation of
- 56:00Speaker 3: the IgG only test because it's only telling you what
- 56:03Speaker 3: you're exposed to.
- 56:04Speaker 4: And again, you're a sharp individual, Michelle.
- 56:06Speaker 3: You know what you're eating, so you know it's kind
- 56:10Speaker 3: of a limited I would say, used to someone you
- 56:13Speaker 3: know who's aware of what they're consuming. And even if
- 56:16Speaker 3: you're not fully aware of what you're consuming, Yeah, that's
- 56:19Speaker 3: not very helpful in terms of from a clinical perspective,
- 56:22Speaker 3: because you want to know what's the root cause what
- 56:25Speaker 3: is it you're consuming? Is is anything you're consuming leading
- 56:30Speaker 3: to the symptoms that you present with when you go
- 56:32Speaker 3: either if you're an annual check you know, or you're
- 56:35Speaker 3: looking for a major reset whatever that might be in
- 56:38Speaker 3: terms of the health journey that we're all on.
- 56:41Speaker 1: Okay, So one thing, another thing I wanted to be sure.
- 56:44Speaker 1: I remember the last time you helped our viewers to
- 56:49Speaker 1: contract to connect with one of your nutrition experts.
- 56:53Speaker 2: Is she the German lady? Is she still is still available?
- 56:58Speaker 3: So again, if anyone's been running the test after this,
- 57:01Speaker 3: we'd be delighted to link her up with doctor Heine.
- 57:06Speaker 3: If you come to the kb m O Diagnostics dot
- 57:09Speaker 3: com website, so that's www dot KBMO diagnostics dot com.
- 57:15Speaker 3: In fact, if you look at the screen, it's underneath
- 57:17Speaker 3: my name there KBMO Diagnostics dot com. And if you
- 57:21Speaker 3: just go to the about you know, the send us
- 57:25Speaker 3: a message on that website and mention more importantly ages
- 57:29Speaker 3: and timeless, and we will will put you in contact
- 57:33Speaker 3: with Silka and she'd be delighted to to help you
- 57:37Speaker 3: a get get you a test kit. As we mentioned,
- 57:39Speaker 3: it can be done at home. So and then more importantly,
- 57:42Speaker 3: she's an amazing provider to kind of then go through
- 57:46Speaker 3: review those results with you. So again, yeah, that would
- 57:48Speaker 3: be uh a very a very good thing for any
- 57:51Speaker 3: one of us to do. Is a not only take
- 57:53Speaker 3: the test, but more importantly have the you know, the
- 57:56Speaker 3: great honor of working with Silco is an amazing europe
- 58:00Speaker 3: In a nutritionist and has many many years of education
- 58:05Speaker 3: as well as running a fit test as well.
- 58:07Speaker 1: And then so people could come to you. Our viewers
- 58:11Speaker 1: can come directly to you, even if they're coming through
- 58:14Speaker 1: a provider, they can do that. If they go to her,
- 58:18Speaker 1: he is provided, but she's within your company exactly.
- 58:22Speaker 4: I can then make sure we can make that happen.
- 58:24Speaker 1: And last time, I think you offered and I don't
- 58:26Speaker 1: want to put you on the spot.
- 58:29Speaker 4: I feel like you are going took anyway.
- 58:32Speaker 1: I think you're very kind and generous and nice.
- 58:34Speaker 2: Why I think I can do that. But I think last.
- 58:36Speaker 1: Time, if they come through the ageless code that they
- 58:40Speaker 1: would get an ageless discount.
- 58:43Speaker 2: So is that still available or we should be Well.
- 58:47Speaker 3: Let me check that with Silka before I say it,
- 58:49Speaker 3: and then go, oh my gosh, okay, potentially, so yeah,
- 58:54Speaker 3: potentially there is a discount available if you mentioned Ageles
- 58:57Speaker 3: and Timeless, and what I'll do is I'll reach out
- 59:00Speaker 3: to Silker make sure that we can we can include that.
- 59:03Speaker 1: Okay, And so just so you know people are not
- 59:06Speaker 1: disappointed if it isn't available, the test costs how much for.
- 59:12Speaker 4: Appreciation, We'll make sure that Silka can provide it.
- 59:14Speaker 3: I don't to be honest, I'm not entirely sure what
- 59:16Speaker 3: her current pricing is because again we don't deal with
- 59:20Speaker 3: the kind of end user price.
- 59:21Speaker 4: We only need to deal with the wholesale price to
- 59:22Speaker 4: the provider.
- 59:24Speaker 2: The providers got it, okay, understood all right?
- 59:27Speaker 1: Well, as always, I'm not sad when we come to
- 59:30Speaker 1: the end of our discussion and that we couldn't get
- 59:33Speaker 1: your test that's up on the screen.
- 59:36Speaker 2: So if people want to look at the test, and
- 59:38Speaker 2: they go on your website and see the sample.
- 59:40Speaker 3: So again, if you go up on the website, you'll
- 59:42Speaker 3: see it under the gut barrier panel. You'll see you'll
- 59:46Speaker 3: see the panel that we're talking about. Hopeful it will
- 59:49Speaker 3: be up afterwards. So again, if there's a follow on
- 59:51Speaker 3: to this, and you know, hopefully we can have that picture.
- 59:54Speaker 3: If not, I can definitely send you on and then
- 59:57Speaker 3: that will be give you access to kind of seeing
- 1:00:00Speaker 3: the test as well.
- 1:00:01Speaker 1: So it's been about a year since I did your night.
- 1:00:04Speaker 1: Last time at the A form, I only did the
- 1:00:07Speaker 1: gut barrier. I didn't do that two years ago we did.
- 1:00:10Speaker 2: The whole thing. Is it possible?
- 1:00:12Speaker 1: I mean, is that about the right time every year
- 1:00:15Speaker 1: to do the gut barrier?
- 1:00:16Speaker 2: A year?
- 1:00:16Speaker 3: I mean, people do it, But again, if you're if
- 1:00:19Speaker 3: you're not feeling any symptoms, or if those symptoms are
- 1:00:21Speaker 3: cleared up, then that's a great thing. But I think
- 1:00:23Speaker 3: the gut barrier is a great one to run because
- 1:00:25Speaker 3: again you can see what might be going on in
- 1:00:28Speaker 3: terms of from an immune health standpoint. And again it's
- 1:00:32Speaker 3: only taken a pandemic for us all to recognize immune
- 1:00:35Speaker 3: health's kind of important.
- 1:00:36Speaker 4: But that's a good thing, and so we can look.
- 1:00:38Speaker 3: At that and kind of give you a good indication
- 1:00:41Speaker 3: of what might be going on.
- 1:00:42Speaker 1: Yeah, I like to do the food sensitivities because I
- 1:00:45Speaker 1: think that is the root cause of a lot of
- 1:00:47Speaker 1: what people have then as a result in the gut
- 1:00:51Speaker 1: barrier panel. So, like you've just described today, I mean,
- 1:00:54Speaker 1: food is oftentimes the root cause of why you're having issues,
- 1:00:59Speaker 1: So I think doing the whole I'm just recommending this
- 1:01:02Speaker 1: to our viewers. I think, do the whole thing, the
- 1:01:05Speaker 1: comprehensive tests, and then can they get a list of
- 1:01:08Speaker 1: providers from your website.
- 1:01:10Speaker 3: If look, if they come into our website that I'll
- 1:01:14Speaker 3: make sure our sales team are then kind of fanning
- 1:01:16Speaker 3: them out to make sure that they've got provided. But
- 1:01:18Speaker 3: to say, given again post pandemic, that we're all more
- 1:01:21Speaker 3: familiar with kind of doing these things, they over zoom
- 1:01:24Speaker 3: right still because.
- 1:01:25Speaker 4: At a great kind of place, or if they want
- 1:01:29Speaker 4: to kind of visit someone, they can they can do
- 1:01:30Speaker 4: that as well.
- 1:01:31Speaker 1: Perfect, Okay, James, Well, the time is gone and they're
- 1:01:36Speaker 1: flagging me to get off, So I always try to
- 1:01:39Speaker 1: keep it within their time frame because I respect them.
- 1:01:42Speaker 2: So I'm really sorry that it ends.
- 1:01:44Speaker 1: But you know, I think we've covered so much ground today,
- 1:01:47Speaker 1: and even though you've come on for a second time,
- 1:01:49Speaker 1: there was a lot of new things that you shared
- 1:01:52Speaker 1: with us today. So I feel like even if people
- 1:01:55Speaker 1: did see the first one, they've learned a lot from
- 1:01:58Speaker 1: the second one. And of course, nothing ever is attic
- 1:02:00Speaker 1: in this world. So well, thank you so much for.
- 1:02:03Speaker 2: Being with us.
- 1:02:05Speaker 4: Thank you.
- 1:02:05Speaker 3: Thank you, Michelle and everyone who listens to a Timeless
- 1:02:08Speaker 3: I think it's an amazing podcast, and again we're very
- 1:02:12Speaker 3: we're a repeat defender and we're back on as.
- 1:02:16Speaker 1: A return favorite to you saying such a wonderful.
- 1:02:18Speaker 2: Thing about us.
- 1:02:19Speaker 1: I'm going to tell you that the other conference I
- 1:02:21Speaker 1: went to was Fab Mancini. It's a small bow cheque
- 1:02:25Speaker 1: conference that you would absolutely love and they had some
- 1:02:28Speaker 1: incredible speakers there, very much like you. So I've got
- 1:02:34Speaker 1: two jobs to do for you. One is to introduce
- 1:02:37Speaker 1: you to Fab and the other one to introduce you
- 1:02:40Speaker 1: to his name.
- 1:02:42Speaker 2: I have to get rad Fest and Fab Mancini.
- 1:02:49Speaker 1: So and the last time this time was in LA
- 1:02:52Speaker 1: but they changed the location for the Fab Mancini one,
- 1:02:56Speaker 1: so you will hear from me soon. But I'm going
- 1:02:59Speaker 1: to make my riches to them for you.
- 1:03:02Speaker 4: Thank you, Thank you again, Michelle, much appreciate, Thanks everyone
- 1:03:05Speaker 4: for listening.
- 1:03:06Speaker 2: Much pire Bye bye h